
OMER vs PCRX
$OMER vs $PCRX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
OMER vs PCRX: the quick read
- ·PCRX is the larger company by market cap ($1.45B vs $1.38B).
- ·OMER has been more active on our scanner (110 vs 72 alerts in 30 days).
- ·PCRX has the smaller float (34.1M vs 66.8M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·Both stay busy on our scanner, 110 and 72 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 5% of each other on market cap, which makes the rest of this table the interesting part.
- ·Both are trading in the upper quarter of their 52-week range, so neither is a pullback candidate right now.
- ·PCRX is the one in play today, trading about 55x its normal volume, which is what puts a name on our scanner in the first place.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing OMER and PCRX on TheDesperateTrader.
- Is OMER or PCRX the better stock?
- "Better" depends on your goal, and these two are not alike. PCRX is the larger company by market cap ($1.45B vs $1.38B). OMER has been more active on our scanner (110 vs 72 alerts in 30 days). PCRX has the smaller float (34.1M vs 66.8M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between OMER and PCRX?
- The differences that matter: they are not in the same business - OMER is pharmaceutical preparations and PCRX is pharmaceutical preparations; they are similar in size ($1.38B vs $1.45B); they trade at very different share prices ($19.47 vs $36.31); OMER sits at 90% of its 52-week range against 99% for PCRX; our scanner flagged OMER 110 times in the last 30 days against 72 for PCRX. Everything above is measured from the latest completed session and SEC filings.
- Which of OMER and PCRX is more active right now?
- Right now OMER is at about 0.6x its normal volume and PCRX is at about 55.3x, so PCRX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading OMER or PCRX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore OMER and PCRX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.